Rate control treatment with calcium channel blockers and beta blockers for patients with atrial fibrillation: a systematic review and meta-analysis
Open Access
- 5 March 2026
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 6 (2)
Abstract
Aims: Controlling heart rate is a key objective in atrial fibrillation (AF) management, commonly achieved with beta blockers or non-dihydropyridine calcium channel blockers, both class I guideline recommendations. However, their long-term effectiveness has rarely been compared. This review aimed to critically evaluate all available evidence comparing these drug classes in AF treatment. Methods and results: We systematically searched MEDLINE, Embase, Web of Science, and Cochrane Central for original studies published up to 1 March 2025. Eligible studies included AF patients, compared calcium channel blockers and beta blockers, and reported heart rate or other clinically relevant outcomes. The primary outcome was 24-hour heart rate on Holter monitoring. Meta-analyses were performed where data were sufficiently homogeneous. Of 1906 identified records, 25 met inclusion criteria. Five studies reported 24-h mean heart rate, showing no difference between drug classes (mean difference: 3.6 b.p.m., 95% CI: −2.9 to 10.1, P = 0.274). Eight studies reported maximum exercise heart rate, which was significantly higher with calcium channel blockers than with beta blockers (mean difference: 10.5 b.p.m., 95% CI: 3.3 to 17.7, P = 0.043). Other outcomes were too heterogeneous for meta-analysis, though three studies reported increased peak oxygen uptake with calcium channel blockers. Conclusion: Calcium channel blockers and beta blockers provide comparable control of mean heart rate in AF. However, patients on calcium channel blockers have a higher maximum heart rate during exercise. In our qualitative synthesis, some studies reported higher peak oxygen uptake calcium channel blocker treated patients, these results should be seen as hypothesis generating.Keywords
Funding Information
- Universitair Medisch Centrum Groningen
This publication has 41 references indexed in Scilit:
- Comparison of non-dihydropyridine calcium channel blockers with beta blockers as treatment for atrial fibrillation: protocol for a systematic review with meta-analysisSystematic Reviews, 2026
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsBMJ, 2021
- Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimensJACC, 1999
- Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover studyInternational Journal of Cardiology, 1995
- Efficacy and safety ofdigoxin alone and in combination with low-dosediltiazem orbetaxolol to control ventricular rate in chronic atrial fibrillationThe American Journal of Cardiology, 1995
- Effects of diltiazem, propranolol, and their combination in the control of atrial fibrillationClinical Cardiology, 1992
- Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillationCardiovascular Research, 1991
- Improved control of atrial fibrillation with combined pindolol and digoxin therapyEuropean Heart Journal, 1989
- Perceived exertion and gas exchange after calcium and beta-blockade in atrial fibrillationJournal of Applied Physiology, 1987
- Treatment of Chronic Atrial Fibrillation in the Elderly, Assessed by Ambulatory Electrocardiographic MonitoringJournal of the American Geriatrics Society, 1980